secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001493152-24-051109
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 1.02, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics issues 1.15M shares at $2.17, terminates GEM SPA and warrant
---------------------------------------------------------------------------

- Sold 1,152,074 shares to GEM at $2.17/share for aggregate $2.5M.
- GEM waived remaining $1.5M commitment fee and terminated outstanding warrant.
- Share purchase agreement with GEM terminated effective December 20, 2024.
- Shares issued in private placement exempt from registration under Section 4(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000149315224051109/0001493152-24-051109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000149315224051109/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-051109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer